Human respiratory epithelial cell culture for drug delivery applications

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 60, Issue 2, 2005, Pages 193-205

  Forbes, Ben ^a   Ehrhardt, Carsten ^b,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SAARLAND UNIVERSITY   (Germany)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Alveolar epithelial cells; Bronchial epithelial cells; In vitro models; Pulmonary drug delivery

Indexed keywords

4 AMINOHIPPURIC ACID; ADRENALIN; ATENOLOL; BROMIDE; BUDESONIDE; CAFFEINE; CIPROFLOXACIN; COCAINE; CROMOGLYCATE DISODIUM; DEXAMETHASONE; DIAZEPAM; DIGOXIN; FLUNISOLIDE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; IMMUNOGLOBULIN A; INULIN; LEUCINE; LUCIFER YELLOW; MACROGOL; METOPROLOL; MORPHINE; NICOTINE; PHENAZONE; PROPRANOLOL; RECOMBINANT HUMAN INSULIN; RHODAMINE 123; RITONAVIR; SALBUTAMOL; SAQUINAVIR; SUCROSE; TETRYLAMMONIUM; THEOPHYLLINE; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; URIDINE; VERAPAMIL; ZIDOVUDINE;

BRONCHUS MUCOSA; CONFERENCE PAPER; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; EPITHELIUM CELL; EVALUATION; HUMAN; LUNG ALVEOLUS CELL; MOLECULAR MODEL; RESPIRATORY SYSTEM;

ABSORPTION; CELL LINE; DRUG DELIVERY SYSTEMS; EPITHELIAL CELLS; HUMANS; LUNG; PERMEABILITY;

EID: 20444378183     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2005.02.010     Document Type: Conference Paper

References (130)

1. I. Gonda The ascent of pulmonary drug delivery J. Pharm. Sci. 87 2000 940 945
2. S. Sanjar, and J. Matthews Treating systemic diseases via the lung J. Aerosol. Med. 14 2001 S51 S58
3. X.M. Zeng, G.P. Martin, and C. Marriott The controlled delivery of drugs to the lung Int. J. Pharm. 124 1995 149 164
4. H.M. Courrier, N. Butz, and T.F. Vandamme Pulmonary drug delivery systems: recent developments and prospects Crit. Rev. Ther. Drug Carrier Syst. 19 2002 425 498
5. D.A. Edwards, and C. Dunbar Bioengineering of therapeutic aerosols Annu. Rev. Biomed. Eng. 4 2002 93 107
6. P. Artursson, K. Palm, and K. Luthman Caco-2 monolayers in experimental and theoretical prediction of drug transport Adv. Drug Deliv. Rev. 22 1996 67 84
7. P. Artursson, and R.T. Borchardt Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond Pharm. Res. 14 1997 1655 1658
8. L.Z. Benet, C.L. Cummins, and C.Y. Wu Transporter-enzyme interactions: implications for predicting drug-drug interactions from in vitro data Curr. Drug Metab. 4 2003 393 398
9. C.R. Lambre, M. Aufderheide, R.E. Bolton, B. Fubini, H.P. Haagsman, P.M. Hext, M. Jorissen, Y. Landry, J.P. Morin, B. Nemery, P. Nettesheim, J. Pauluhn, R.J. Richards, A.E.M. Vickers, R. Wu, In vitro tests for respiratory toxicity - the report and recommendations of ECVAM workshop 18, ATLA 24, 1996, pp. 671-681.
10. C. Mobley, and G. Hochhaus Methods used to assess pulmonary deposition and absorption of drugs Drug Discov. Today 6 2001 367 375
11. L.S. Schanker Drug absorption from the lung Biochem. Pharmacol. 27 1978 381 385
12. J. Widdecombe Airway permeability and alveolar permeability and surface liquid thickness: theory J. Appl. Physiol. 82 1997 3 12
13. P. Flecknell Replacement, reduction, refinement ALTEX 19 2002 73 78
14. I.D. Wakefield, C. Pollard, W.S. Redfern, T.G. Hammond, and J.P. Valentin The application of in vitro methods to safety pharmacology Fundam. Clin. Pharmacol. 16 2002 209 218
15. A.J. Hussain, L.J. Lesko, K.Y. Lo, V.P. Shah, D. Volpe, and R.L. Williams The biopharmaceutics classification system: highlights of FDA's draft guidance Dissolution Technol. 6 1999 5 9
16. A. Tronde, B. Norden, H. Marchner, A.K. Wendel, H. Lennernas, and U.H. Bengtsson Pulmonary absorption rate and bioavailability of drugs in vivo in rats: structure-absorption relationships and physicochemical profiling of inhaled drugs J. Pharm. Sci. 92 2003 1216 1233
17. B. Forbes Human airway epithelial cell lines for in vitro drug transport and metabolism studies Pharm. Sci. Technol. Today 3 2000 18 27
18. N.R. Mathias, F. Yamashita, and V.H.L. Lee Respiratory epithelial cell culture models for evaluation of ion and drug transport Adv. Drug Deliv. Rev. 22 1996 215 249
19. S. Jonsson, D.M. Musher, A. Goree, and E.C. Lawrence Human alveolar lining material and antibacterial defenses Am. Rev. Respir. Dis. 133 1986 136 140
20. I.M. McKenna, T. Gordon, L.C. Chen, M.R. Anver, and M.P. Waalkes Expression of metallothionein protein in the lungs of Wistar rats and C57 and DBA mice exposed to cadmium oxide fumes Toxicol. Appl. Pharmacol. 153 1998 169 178
21. P.J. Henry Endothelin receptor distribution and function in the airways Clin. Exp. Pharmacol. Physiol. 26 1999 16216 16217
22. R.U. Agu, M.I. Ugwoke, M. Armand, R. Kinget, and N. Verbeke The lung as a route for systemic delivery of therapeutic proteins and peptides Respir. Res. 2 2001 198 209
23. P.R. Byron, and J.S. Patton Drug delivery via the respiratory tract J. Aerosol. Med. 7 1994 49 75
24. D.A. Groneberg, C. Witt, U. Wagner, K.F. Chung, and A. Fischer Fundamentals of pulmonary drug delivery Respir. Med. 97 2003 382 387
25. M. Gumbleton Caveolae as potential macromolecule trafficking compartments within alveolar epithelium Adv. Drug Deliv. Rev. 49 2001 281 300
26. J.G. Hardy, and T.S. Chadwick Sustained release drug delivery to the lungs - an option for the future Clin. Pharmacokinet. 39 2000 1 4
27. N.R. Labiris, and M.B. Dolovich Pulmonary drug delivery. Part I. Physiological factors affecting therapeutic effectiveness of aerosolized medications Br. J. Clin. Pharmacol. 56 2003 588 599
28. A.B. Lansley Mucociliary clearance and drug-delivery via the respiratory tract Adv. Drug Deliv. Rev. 11 1993 299 327
29. J.S. Patton Mechanisms of macromolecule absorption by the lungs Adv. Drug Deliv. Rev. 19 1996 3 36
30. J.W. Yu, and Y.W. Chien Pulmonary drug delivery: physiologic and mechanistic aspects Crit. Rev. Ther. Drug Carrier Syst. 14 1997 395 453
31. K.J. Elbert, U.F. Schäfer, H.J. Schäfers, K.J. Kim, V.H.L. Lee, and C.M. Lehr Monolayers of human alveolar epithelial cells in primary culture for pulmonary absorption and transport studies Pharm. Res. 16 1999 601 608
32. M. Yamaya, W.E. Finkbeiner, S.Y. Chun, and J.H. Widdecombe Differentiated structure and function of cultures from human tracheal epithelium Am. J. Physiol. 262 1992 L713 L724
33. J.H. Widdecombe, L.A. Sachs, and W.E. Finkbeiner Effects of growth surface on differentiation of cultures of human tracheal epithelium In Vitro Cell Dev. Biol. 39 2003 51 55
34. L.A. Sachs, W.E. Finkbeiner, and J.H. Widdecombe Effects of media on differentiation of cultured human tracheal epithelium In Vitro Cell Dev. Biol. 39 2003 56 62
35. http://www.mattek.com/pages/products/epiairway.
36. A.L. Cozens, M.J. Yezzi, K. Kunzelmann, T. Ohrui, L. Chin, K. Eng, W.E. Finkbeiner, J.H. Widdicombe, and D.C. Gruenert CFTR expression chloride secretion in polarized immortal human bronchial epithelial cells Am. J. Respir. Cell Mol. Biol. 10 1994 38 47
37. B.Q. Shen, W.E. Finkbeiner, J.J. Wine, R.J. Mrsny, and J.H. Widdicombe Calu-3: a human airway epithelial cell line that shows cAMP-dependent Cl-secretion Am. J. Physiol. 266 1994 L493 L501
38. C. Ehrhardt, C. Kneuer, J. Fiegel, J. Hanes, U.F. Schaefer, K.J. Kim, and C.M. Lehr Influence of apical fluid volume on the development of functional intercellular junctions in the human epithelial cell line 16HBE14o-: implications for the use of this cell line as an in vitro model for bronchial drug absorption studies Cell Tissue Res. 308 2002 391 400
39. B. Forbes, A. Shah, G.P. Martin, and A.B. Lansley The human bronchial epithelial cell line 16HBE14o- as a model system of the airways for studying drug transport Int. J. Pharm. 257 2003 61 167
40. N.R. Mathias, J. Timoszyk, P.I. Stetsko, J.R. Megill, R.L. Smith, and D.A. Wall Permeability characteristics of Calu-3 human bronchial epithelial cells: in vitro-in vivo correlation to predict lung absorption in rats J. Drug Target. 10 2002 31 40
41. C. Meaney, B.I. Florea, C. Ehrhardt, U.F. Schaefer, C.M. Lehr, H.E. Junginger, and G. Borchard Bronchial epithelial cell cultures C.M. Lehr Cell Culture Models of Biological Barriers 2002 Taylor and Francis London 211 227
42. B.I. Florea, M.L. Cassara, H.E. Junginger, and G. Borchard Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3 J. Control Rel. 87 2003 131 138
43. I. Pezron, R. Mitra, D. Pal, and A.K. Mitra Insulin aggregation and asymmetric transport across human bronchial epithelial cell monolayers (Calu-3) J. Pharm. Sci. 91 2002 1135 1146
44. P.M. de Jong, M.A.J.A. van Sterkenberg, S.C. Hesseling, J.A. Kempenaar, A.A. Mulder, A.M. Mommaas, J.H. Dijkman, and M. Ponec Ciliogenesis in human bronchial epithelial cells cultured at the air-liquid interface Am. J. Respir. Cell Mol. Biol. 10 1994 271 299
45. J. Fiegel, C. Ehrhardt, U.F. Schaefer, C.M. Lehr, and J. Hanes Large porous particle impingement on lung epithelial cell monolayers - toward improved particle characterization in the lung Pharm. Res. 20 2003 788 796
46. I. Behrens, and T. Kissel Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers? Eur. J. Pharm. Sci. 19 2003 433 442
47. M.J. Briske-Anderson, J.W. Finley, and S.M. Newman The influence of culture time and passage number on the morphological and physiological development of Caco-2 cells Proc. Soc. Exp. Biol. Med. 214 1997 248 257
48. J.D. Crapo, B.E. Barry, P. Gehr, M. Bachofen, and E.R. Weibel Cell number and cell characteristics of the normal human lung Am. Rev. Respir. Dis. 126 1982 332 337
49. H. Fehrenbach Alveolar epithelial type II cell: defender of the alveolus revisited Respir. Res. 2 2001 33 46
50. M.C. Williams Alveolar type I cells: molecular phenotype and development Annu. Rev. Physiol. 65 2003 669 695
51. K.J. Kim, Z. Borok, and E.D. Crandall A useful in vitro model for transport studies of alveolar epithelial barrier Pharm. Res. 18 2001 253 255
52. S. Kobayashi, S. Kondo, and K. Juni Permeability of peptides and proteins in human cultured alveolar A549 cell monolayer Pharm. Res. 12 1995 1115 1119
53. Z. Wang, and Q. Zhang Transport of proteins and peptides across human cultured alveolar A549 cell monolayer Int. J. Pharm. 269 2004 451 456
54. B.E. Goodman, and E.D. Crandall Dome formation in primary cultured monolayers of alveolar epithelial cells Am. J. Physiol. 243 1982 C96 C100
55. J.M. Cheek, M.J. Evans, and E.D. Crandall Type I cell-like morphology in tight alveolar epithelial monolayers Exp. Cell Res. 184 1989 3753 3787
56. Z. Borok, S.I. Danto, S.M. Zabski, and E.D. Crandall Defined medium for primary culture de novo of adult rat alveolar epithelial cells In Vitro Cell Dev. Biol. 30A 1994 99 104
57. M. Corti, A.R. Brody, and J.H. Harrison Isolation and primary culture of murine alveolar type II cells Am. J. Respir. Cell Mol. Biol. 14 1996 309 315
58. J. Shen, K.J. Elbert, F. Yamashita, C.M. Lehr, K.J. Kim, and V.H.L. Lee Organic cation transport in rabbit alveolar epithelial cell monolayers Pharm. Res. 16 1999 1280 1287
59. C. Gindorf, A. Steimer, C.M. Lehr, U. Bock, S. Schmitz, and E. Haltner Marker transport across biological barriers in vitro: comparison of cell culture models for the gastrointestinal barrier, the blood-brain barrier and the alveolar epithelium of the lung ALTEX 18 2001 155 165
60. G.E. Milo, G.A. Ackerman, and R.L. Sanders Growth characteristics, morphology, and phospholipid composition of human type II pulmonary alveolar cells grown in a collagen-free microenvironment In Vitro 20 1984 899 911
61. S. Fuchs, A.J. Hollins, M. Laue, U.F. Schaefer, K. Roemer, M. Gumbleton, and C.M. Lehr Differentiation of human alveolar epithelial cells in primary culture - morphological characterisation and expression of caveolin-1 and surfactant protein-C Cell Tissue Res. 311 2003 31 45
62. K.J. Elbert, Alveolare Epithelzellkultursysteme als in vitro-Modell für die pulmonale Absorption von Arzneistoffen, Thesis, Saarland University, Saarbrücken, Germany, 1998.
63. M. Kasper, and G. Singh Epithelial lung cell marker: current tools for cell typing Histol. Histopathol. 10 1995 155 169
64. S.M. Kreda, M.C. Gynn, D.A. Fenstermacher, R.C. Boucher, and S.E. Gabriel Expression and localization of epithelial aquaporins in the adult human lung Am. J. Respir. Cell Mol. Biol. 24 2001 224 234
65. G.R. Newman, L. Campbell, C. von Ruhland, B. Jasani, and M. Gumbleton Caveolin and its cellular and subcellular immunolocalisation in lung alveolar epithelium: implications for alveolar type I cell function Cell Tissue Res. 295 1999 111 120
66. M. Shirasawa, N. Fujiwara, S. Hirabayashi, H. Ohno, J. Iida, K. Makita, and Y. Hata Receptor for advanced glycation end-products is a marker of type I lung alveolar cells Genes Cells 9 2004 165 174
67. H. Fehrenbach, M. Kasper, T. Tschernig, M.S. Shearman, D. Schuh, and M. Muller Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung Cell. Mol. Biol. 44 1998 1147 1157
68. B.E. Isakson, G.J. Seedorf, R.L. Lubman, and S. Boitano Heterocellular cultures of pulmonary alveolar epithelial cells grown on laminin-5 supplemented matrix In Vitro Cell Dev. Biol. Anim. 38 2002 443 449
69. B. Forbes, and A.B. Lansley Differences in drug transport across bronchial and gastrointestinal drug absorption models J. Pharm. Pharmacol. 50 1998 96
70. B. Forbes, and A.B. Lansley Transport characteristics of formoterol and salbutamol across a bronchial epithelial drug absorption model Eur. J. Pharm. Sci. 6 1998 S24
71. C.S. O'Shaughnessy, and E.S. Prosser Calu-3 in the horizontal diffusion chamber system, a model of pulmonary drug transport Pharm. Res. 13 1996 S169
72. P. Artursson Epithelial transport of drugs in cell culture I. A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells J. Pharm. Sci. 79 1990 476 482
73. P. Saha, K.J. Kim, H. Yamahara, E.D. Crandall, and V.H.L. Lee Influence of lipophilicity on beta-blocker permeation across rat alveolar epithelial monolayers J. Control Rel. 32 1994 191 200
74. J.D. Irvine, L. Takahashi, K. Lockhart, J. Cheong, J.W. Tolan, H.E. Selick, and J.R. Grove MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening J. Pharm. Sci. 88 1999 28 33
75. A. Tronde, B. Norden, A.B. Jeppsson, P. Brunmark, E. Nilsson, H. Lennernas, and U.H. Bengtsson Drug absorption from the isolated perfused rat lung - correlations with drug physicochemical properties and epithelial permeability J. Drug Target. 11 2003 61 74
76. K.O. Hamilton, E. Topp, I. Makagiansar, T. Siahaan, M. Yazdanian, and K.L. Audus Multidrug resistance-associated protein-1 functional activity in Calu-3 cells J. Pharmacol. Exp. Ther. 298 2001 1199 1205
77. T.H. Gardiner, and L.S. Schanker Active transport of phenol red by rat lung slices J. Pharmacol. Exp. Ther. 196 1976 455 462
78. D.A. Groneberg, M. Nickolaus, J. Springer, F. Doring, H. Daniel, and A. Fischer Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake Am. J. Pathol. 158 2001 707 714
79. K.O. Hamilton, G. Backstrom, M.A. Yazdanian, and K.L. Audus P-glycoprotein efflux pump expression and activity in Calu-3 cells J. Pharm. Sci. 90 2001 647 658
80. C. Ehrhardt, C. Kneuer, M. Laue, U.F. Schaefer, K.J. Kim, and C.M. Lehr 16HBE14o- human bronchial epithelial cell layers express P-glycoprotein, lung resistance-related protein, and caveolin-1 Pharm. Res. 20 2003 545 551
81. J. Patel, D. Pal, V. Vangal, M. Gandhi, and A.L. Mitra Transport of HIV-gprotease inhibitors across 1 alpha,25di-hydroxy vitamin D3-treated Calu-3 cell monolayers: modulation of P-glycoprotein activity Pharm. Res. 19 2002 1696 1703
82. M.E. Cavet, M. West, and N.L. Simmons Transepithelial transport of the fluoroquinolone ciprofloxacin by human airway epithelial Calu-3 cells Antimicrob. Agents Chemother. 41 1997 2693 2698
83. G. Borchard, M.L. Cassara, P.E. Roemele, B.I. Florea, and H.E. Junginger Transport and local metabolism of budesonide and fluticasone propionate in a human bronchial epithelial cell line (Calu-3) J. Pharm. Sci. 91 2002 1561 1567
84. K.O. Hamilton, M.A. Yazdanian, and K.L. Audus Contribution of efflux pump activity to the delivery of pulmonary therapeutics Curr. Drug Metab. 3 2002 1 12
85. C. Ehrhardt, C. Bies, C. Kneuer, U. Bakowsky, K.J. Kim, C.M. Lehr, Salbutamol is actively absorbed across human bronchial epithelial cell layers, Pulm. Pharmacol. Ther. 3 (2005) 165-170.
86. F. Ahsan, J.J. Arnold, T. Yang, E. Meezan, E.M. Schwiebert, and D.J. Pillion Effects of the permeability enhancers, tetradecylmaltoside and dimethyl-beta-cyclodextrin, on insulin movement across human bronchial epithelial cells (16HBE14o-) Eur. J. Pharm. Sci. 20 2003 27 34
87. B.I. Florea, I.C. van der Sandt, S.M. Schrier, K. Kooiman, K. Deryckere, A.G. de Boer, H.E. Junginger, and G. Borchard Evidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3) Br. J. Pharmacol. 134 2001 1555 1563
88. S. Fuchs, Humane alveolare Epithelzellen in Primärkultur: Zellbiologische Charakterisierung, Transporteigenschaften und Transduktion mit retroviralen Vektoren zur Verlängerung der Lebensdauer, Thesis, Saarland University, Saarbrücken, Germany, 2003.
89. K.J. Kim, and A.B. Malik Protein transport across the lung epithelial barrier Am. J. Physiol. 284 2003 L247 L259
90. M. Bhat, D. Toledo-Velasquez, L. Wang, C.J. Malanga, J.K.H. Ma, and Y. Rojanasakul Regulation of tight junction permeability by calcium chelators and cell cytoskeleton in rabbit tracheal epithelium Pharm. Res. 10 1993 991 997
91. Y. Rojanasakul, L. Wang, M. Bhat, D.D. Glover, C.J. Malanga, and J.K.H. Ma The transport barrier of epithelia: comparative study on membrane permeability and charge selectivity in rabbit Pharm. Res. 9 1992 1029 1034
92. R.M. Effros, G.R. Mason, Measurements of pulmonary epithelial permeability in vivo, Am. Rev. Respir. Dis. 127(1983) S59-S65.
93. Y. Matsukawa, H. Yamahara, F. Yamashita, V.H.L. Lee, E.D. Crandall, and K.J. Kim Rates of protein transport across rat alveolar epithelial cell monolayers J. Drug Target. 7 2000 335 342
94. H. Winton, H. Wan, M.B. Cannell, D.C. Gruenert, P.J. Thompson, D.R. Garrod, G.A. Stewart, and C. Robinson Cell lines of pulmonary and non-pulmonary origin as tools to study the effects of house dust mite proteinases on the regulation of epithelial permeability Clin. Exp. Allergy 28 1998 1273 1285
95. K.A. Foster, C.G. Oster, M.M. Mayer, M.L. Avery, and K.L. Audus Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism Exp. Cell Res. 243 1998 359 366
96. J. Hukkanen, O. Pelkonen, and H. Raunio Expression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD Eur. Respir. J. 32 2001 122s 126s
97. P.L. Sheets, G.S. Yost, and G.P. Carlson Benzene metabolism in human lung cell lines BEAS-2B and A549 and cells overexpressing CYP2F1 J. Biochem. Mol. Toxicol. 18 2004 92 99
98. K. Mace, E.D. Bowman, P. Vautravers, P.G. Shields, C.C. Harris, and A.M. Pfeifer Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues Eur. J. Cancer 34 1998 914 920
99. Y. Kuzuya, T. Adachi, H. Hara, A. Anan, K. Izuhara, and H. Nagai Induction of drug-metabolizing enzymes and transporters in human bronchial epithelial cells by beclomethasone dipropionate IUBMB Life 56 2004 355 359
100. K.A. Foster, M.L. Avery, M. Yazdanian, and K.L. Audus Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery Int. J. Pharm. 208 2000 1 11
101. A.C. Collier, M.D. Tingle, J.A. Keelan, J.W. Paxton, and M.D. Mitchell A highly sensitive fluorescent microplate method for the determination of UDP-glucuronosyl transferase activity in tissues and placental cell lines Drug Metab. Dispos. 28 2000 1184 1186
102. B. Forbes, C.G. Wilson, and M. Gumbleton Temporal dependence of ectopeptidase expression in alveolar epithelial cell culture: implications for study of peptide absorption Int. J. Pharm. 180 1999 225 234
103. D. Proud, M.C. Subauste, and P.E. Ward Glucocorticoids do not alter peptidase expression in on a human bronchial epithelial cell line Am. J. Respir. Cell Mol. Biol. 11 1994 57 65
104. R. Trehin, H.M. Nielsen, H.G. Jahnke, A.G. Beck-Sickinger, and H. Merkle Metabolic cleavage of cell-penetrating peptides in ncontact with epithelial models: human calcitonin (hCT)-derived peptides Tat (47-57) and penetratin (43-58) Biochem. J. 382 2004 924 956
105. M.R. Wilson, V. Stone, R.T. Cullen, A. Searl, R.L. Maynard, and K. Donaldson In vitro toxicology of respirable Montserrat volcanic ash Occup. Environ. Med. 57 2000 727 733
106. M. Laan, S. Bozinovski, and G. Anderson Cigarette smoke inhibits lipopolysaccharide-induced production of inflammatory cytokines by suppressing the activation of activator protein-1 in bronchial epithelial cells J. Immunol. 173 2004 4164 4170
107. S. Kawasaki, H. Takizawa, K. Takami, M. Desaki, H. Okazaki, T. Kasama, K. Kobayashi, K. Yamamoto, K. Nakahara, M. Tanaka, M. Sagai, and T. Ohtoshi Benzene-extracted components are important for the major activity of diesel exhaust particles - effect on interleukin-8 gene expression in human bronchial epithelial cells Am. J. Respir. Cell Mol. Biol. 24 2001 419 426
108. C. Westmoreland, T. Walker, J. Matthews, and J. Murdock Preliminary investigations into the use of a human bronchial cell line (16HBE14o-) to screen for respiratory toxins in vitro Toxicol. In Vitro 13 1999 761 764
109. B. Forbes, N. Hashmi, G.P. Martin, and A.B. Lansley Formulation of inhaled medicines: effect of delivery vehicle on immortalized epithelial cells J. Aerosol. Med. 13 2000 281 288
110. T.Z. Yang, F. Mustafa, S.H. Bai, and F. Ahsan Pulmonary delivery of low molecular weight heparins Pharm. Res. 21 2004 2009 2016
111. M. Bivas-Benita, S. Romeijn, H.E. Junginger, and G. Borchardt PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium Eur. J. Pharm. Biopharm. 58 2004 1 6
112. J. Bastacky, C.Y. Lee, J. Goerke, H. Koushafar, D. Yager, L. Kenaga, T.P. Speed, Y. Chen, and J.A. Clements Alveolar lining layer is thin and continuous: low-temperature scanning electron microscopy of rat lung J. Appl. Physiol. 79 1995 1615 1628
113. E.R. Weibel Morphometry of the Human Lung 1963 Academic Press New York
114. C. Witschi, and R.J. Mrsny In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery Pharm. Res. 16 1999 382 390
115. K. Koushik, D.S. Dhanda, N.P. Cheruvu, and U.B. Kompella Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes Pharm. Res. 21 2004 1119 1126
116. M. Brzoska, K. Langer, C. Coester, S. Loitsch, T.O. Wagner, and C. Mallinckrodt Incorporation of biodegradable nanoparticles into human airway epithelium cells-in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases Biochem. Biophys. Res. Commun. 318 2004 562 570
117. K.A. Foster, M. Yazdanian, and K.L. Audus Microparticulate uptake mechanisms of in vitro cell culture models of the respiratory epithelium J. Pharm. Pharmacol. 53 2001 57 66
118. B. Forbes, S. Lim, G.P. Martin, and M.B. Brown An in vitro technique for evaluating inhaled nasal delivery systems STP Pharma. Sci. 12 2002 75 79
119. Y. Qi, G. Zhao, D. Liu, Z. Shriver, M. Sundaram, S. Sengupta, G. Ventataraman, R. Langer, and R. Sasisekharan Delivery of therapeutic levels of heparin and low-molecular weight heparin through a pulmonary route Proc. Natl Acad. Sci. 101 2004 9867 9872
120. A. Hussain, T. Yang, A.A. Zaghloul, and F. Ahsan Pulmonary absorption of insulin mediated by tetradecyl-beta-maltoside and dimethyl-beta-cyclodextrin Pharm. Res. 20 2003 1551 1557
121. S.T. Lim, B. Forbes, G.P. Martin, and M.B. Brown In vivo and in vitro characterization of novel microparticles based on hyaluronan and chitosan hydroglutamate AAPS Pharma Sci Tech 2 2001 1 14
122. B.I. Florea, T.J. Molenaar, I. Bot, I.N. Michon, J. Kuiper, T.J. van Berkel, H.E. Junginger, E.A. Biessen, and G. Borchard Identification of an internalising peptide in differentiated Calu-3 cells by phage display technology; application to gene delivery to the airways J. Drug Target. 11 2003 383 390
123. P. Delepine, C. Guillaume, T. Montier, J.C. Clement, J.J. Yaouanc, H. des Abbayes, F. Berthou, A Le Pape, and C. Ferec Biodistribution study of phosphonolipids: a class of non-viral vectors efficient in mice lung-directed gene transfer J. Gene Med. 5 2003 600 608
124. H. Wan, H.L. Winton, C. Soeller, G.A. Stewart, P.J. Thompson, D.C. Gruenert, M.B. Cannell, D.R. Garrod, and C. Robinson Tight junction properties of the immortalized human bronchial epithelial cell lines Calu-3 and 16HBE14o- Eur. Respir. J. 15 2000 1058 1068
125. C. Ehrhardt, J. Fiegel, S. Fuchs, R. Abu-Dahab, U.F. Schaefer, J. Hanes, and C.M. Lehr Drug absorption by the respiratory mucosa: cell culture models and particulate drug carriers J. Aerosol. Med. 15 2002 131 139
126. C. Ehrhardt, Characterisation of epithelial cell culture models of the lung for in vitro studies of pulmonary drug delivery, Thesis, Saarland University, Saarbrücken, Germany, 2003.
127. K.A. Foster, M.L. Avery, M. Yazdanian, and K.L. Audus Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery Int. J. Pharm. 208 2000 1 11
128. S. Loman, J. Radl, H.M. Jansen, T.A. Out, and R. Lutter Vectorial transcytosis of dimeric IgA by the Calu-3 human lung epithelial cell line: upregulation by IFN-gamma Am. J. Physiol. 272 1997 L951 L958
129. N.R. Mathias, K.J. Kim, T.W. Robison, and V.H.L. Lee Development and characterization of rabbit tracheal epithelial cell monolayer models for drug transport studies Pharm. Res. 12 1995 1499 1505
130. M. Leonard, E. Creed, D. Brayden, and A.W. Baird Evaluation of the Caco-2 monolayer as a model epithelium for iontophoretic transport Pharm. Res. 17 2000 1181 1188